{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:50:43Z","timestamp":1760575843914,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"DOI":"10.7759\/cureus.94642","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:09Z","timestamp":1760539629000},"source":"Crossref","is-referenced-by-count":0,"title":["A Review of the Management of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Rakhul","family":"Raveendran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320430309","article-title":"Autosomal dominant polycystic kidney disease: new information for genetic counselling","volume":"43","author":"Bear JC","year":"1992","unstructured":"Bear JC, Parfrey PS, Morgan JM, Martin CJ, Cramer BC. Autosomal dominant polycystic kidney disease: new information for genetic counselling. Am J Med Genet. 1992, 43:548-53. 10.1002\/ajmg.1320430309","journal-title":"Am J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80004-4","article-title":"Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis","volume":"5","author":"Delaney VB","year":"1985","unstructured":"Delaney VB, Adler S, Bruns FJ, Licinia M, Segel DP, Fraley DS. Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. Am J Kidney Dis. 1985, 5:104-11. 10.1016\/S0272-6386(85)80004-4","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80137-9","article-title":"The association of nephrolithiasis and autosomal dominant polycystic kidney disease","volume":"11","author":"Torres V","year":"1988","unstructured":"Torres V, Erickson S, Smith L, Wilson D, Hattery R, Segura J. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988, 11:318-25. 10.1016\/S0272-6386(88)80137-9","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2478\/s11536-011-0043-z","article-title":"Prevalence of nephrolithiasis in polycystic kidney disease","volume":"6","author":"Idrizi A","year":"2011","unstructured":"Idrizi A, Barbullushi M, Gjata M, Koroshi A, Roshi E, Backa T. Prevalence of nephrolithiasis in polycystic kidney disease. Cent Eur J Med. 2011, 6:497. 10.2478\/s11536-011-0043-z","journal-title":"Cent Eur J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80922-X","article-title":"Renal stone disease in autosomal dominant polycystic kidney disease","volume":"22","author":"Torres VE","year":"1993","unstructured":"Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993, 22:513-9. 10.1016\/S0272-6386(12)80922-X","journal-title":"Am J Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-0090-z","article-title":"Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?","volume":"44","author":"Srivastava A","year":"2012","unstructured":"Srivastava A, Bansal R, Srivastava A, et al.. Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?. Int Urol Nephrol. 2012, 44:725-30. 10.1007\/s11255-011-0090-z","journal-title":"Int Urol Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0093","article-title":"Nephrolithiasis in autosomal dominant polycystic kidney disease","volume":"24","author":"Mufti UB","year":"2010","unstructured":"Mufti UB, Nalagatla SK. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol. 2010, 24:1557-61. 10.1089\/end.2010.0093","journal-title":"J Endourol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67792-0","article-title":"Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management","volume":"163","author":"Ng CS","year":"2000","unstructured":"Ng CS, Yost A, Streem SB. Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management. J Urol. 2000, 163:726-9. 10.1016\/S0022-5347(05)67792-0","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-03979-7","article-title":"The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease","volume":"26","author":"Elcioglu OC","year":"2025","unstructured":"Elcioglu OC, Yatci B, Ozturk BB, Mirioglu S, Gursu M, Kazancioglu R. The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease. BMC Nephrol. 2025, 26:94. 10.1186\/s12882-025-03979-7","journal-title":"BMC Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.07.036","article-title":"Percutaneous nephrolithotomy for management of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease","volume":"74","author":"Al-Kandari AM","year":"2009","unstructured":"Al-Kandari AM, Shoma AM, Eraky I, El-Kenawy MR, Al-Eezi H, El-Kappany HA. Percutaneous nephrolithotomy for management of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease. Urology. 2009, 74:273-7. 10.1016\/j.urology.2008.07.036","journal-title":"Urology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-005-0019-z","article-title":"Lithiasis in cystic kidney disease and malformations of the urinary tract","volume":"34","author":"Gambaro G","year":"2006","unstructured":"Gambaro G, Fabris A, Puliatta D, Lupo A. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res. 2006, 34:102-7. 10.1007\/s00240-005-0019-z","journal-title":"Urol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.8266","article-title":"Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Grampsas SA","year":"2000","unstructured":"Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Johnson AM, Gabow P. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000, 36:53-7. 10.1053\/ajkd.2000.8266","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease","volume":"30","author":"Mao Z","year":"2015","unstructured":"Mao Z, Xie G, Ong AC. Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2015, 30:197-203. 10.1093\/ndt\/gfu044","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.08.141","article-title":"Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease","volume":"183","author":"Umbreit EC","year":"2010","unstructured":"Umbreit EC, Childs MA, Patterson DE, Torres VE, LeRoy AJ, Gettman MT. Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease. J Urol. 2010, 183:183-7. 10.1016\/j.juro.2009.08.141","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.159.1.1609726","article-title":"Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients","volume":"159","author":"Levine E","year":"1992","unstructured":"Levine E, Grantham JJ. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol. 1992, 159:77-81. 10.2214\/ajr.159.1.1609726","journal-title":"AJR Am J Roentgenol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients","volume":"4","author":"Nishiura JL","year":"2009","unstructured":"Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2009, 4:838-44. 10.2215\/CJN.03100608","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2221010453","article-title":"US for detecting renal calculi with nonenhanced CT as a reference standard","volume":"222","author":"Fowler KA","year":"2002","unstructured":"Fowler KA, Locken JA, Duchesne JH, Williamson MR. US for detecting renal calculi with nonenhanced CT as a reference standard. Radiology. 2002, 222:109-13. 10.1148\/radiol.2221010453","journal-title":"Radiology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00987-0","article-title":"Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management","volume":"175","author":"Hoppe H","year":"2006","unstructured":"Hoppe H, Studer R, Kessler TM, Vock P, Studer UE, Thoeny HC. Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol. 2006, 175:1725-30. 10.1016\/S0022-5347(05)00987-0","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman AB","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, et al.. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015, 88:17-27. 10.1038\/ki.2015.59","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/end.1997.11.167","article-title":"Extracorporeal shockwave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease","volume":"11","author":"Delakas D","year":"1997","unstructured":"Delakas D, Daskalopoulos G, Cranidis A. Extracorporeal shockwave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease. J Endourol. 1997, 11:167-70. 10.1089\/end.1997.11.167","journal-title":"J Endourol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2002.00410.x","article-title":"Extracorporeal shock wave lithotripsy produces a lower stone-free rate in patients with stones and renal cysts","volume":"9","author":"Deliveliotis C","year":"2002","unstructured":"Deliveliotis C, Argiropoulos V, Varkarakis J, Albanis S, Skolarikos A. Extracorporeal shock wave lithotripsy produces a lower stone-free rate in patients with stones and renal cysts. Int J Urol. 2002, 9:11-4. 10.1046\/j.1442-2042.2002.00410.x","journal-title":"Int J Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67657-2","article-title":"Extracorporeal shock wave lithotripsy for renal stones with renal cysts present","volume":"153","author":"Cass A","year":"1995","unstructured":"Cass A. Extracorporeal shock wave lithotripsy for renal stones with renal cysts present. J Urol. 1995, 153:599-601. 10.1016\/S0022-5347(01)67657-2","journal-title":"J Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.91618","article-title":"Management of nephrolithiasis in autosomal dominant polycystic kidney disease - a single center experience","volume":"4","author":"Baishya R","year":"2012","unstructured":"Baishya R, Dhawan DR, Kurien A, Ganpule A, Sabnis RB, Desai MR. Management of nephrolithiasis in autosomal dominant polycystic kidney disease - a single center experience. Urol Ann. 2012, 4:29-33. 10.4103\/0974-7796.91618","journal-title":"Urol Ann"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000474653","article-title":"Place of double-J stents in extracorporeal shock wave lithotripsy","volume":"23","author":"Kirkali Z","year":"1993","unstructured":"Kirkali Z, Esen AA, Akan G. Place of double-J stents in extracorporeal shock wave lithotripsy. Eur Urol. 1993, 23:460-2. 10.1159\/000474653","journal-title":"Eur Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1089\/end.1996.10.341","article-title":"Outcome assessment of double-J stents during extracorporeal shockwave lithotripsy of small solitary renal calculi","volume":"10","author":"Low RK","year":"1996","unstructured":"Low RK, Stoller ML, Irby P, Keeler L, Elhilali M. Outcome assessment of double-J stents during extracorporeal shockwave lithotripsy of small solitary renal calculi. J Endourol. 1996, 10:341-3. 10.1089\/end.1996.10.341","journal-title":"J Endourol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-011-0390-x","article-title":"Flexible ureteroscopy and holmium laser lithotripsy for treatment of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease","volume":"40","author":"Yili L","year":"2012","unstructured":"Yili L, Yongzhi L, Ning L, Dongwei X, Chunlai L, Suomin L, Ping W. Flexible ureteroscopy and holmium laser lithotripsy for treatment of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease. Urol Res. 2012, 40:87-91. 10.1007\/s00240-011-0390-x","journal-title":"Urol Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/2054358120940433","article-title":"Efficacy and safety of surgical kidney stone interventions in autosomal dominant polycystic kidney disease: a systematic review","volume":"7","author":"Kalatharan V","year":"2020","unstructured":"Kalatharan V, Jandoc R, Grewal G, et al.. Efficacy and safety of surgical kidney stone interventions in autosomal dominant polycystic kidney disease: a systematic review. Can J Kidney Health Dis. 2020, 7:2054358120940433. 10.1177\/2054358120940433","journal-title":"Can J Kidney Health Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14575","article-title":"Changing trends in the endourological management of urolithiasis in anomalous kidneys","volume":"123","author":"Singh AG","year":"2019","unstructured":"Singh AG, Jairath A, Balaji SS, et al.. Changing trends in the endourological management of urolithiasis in anomalous kidneys. BJU Int. 2019, 123:318-27. 10.1111\/bju.14575","journal-title":"BJU Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000343545","article-title":"Percutaneous Nephrolithotomy in autosomal dominant polycystic kidney disease: is it different from percutaneous nephrolithotomy in normal kidney?","volume":"7","author":"Singh V","year":"2013","unstructured":"Singh V, Sinha RJ, Gupta DK. Percutaneous Nephrolithotomy in autosomal dominant polycystic kidney disease: is it different from percutaneous nephrolithotomy in normal kidney?. Curr Urol. 2013, 7:7-13. 10.1159\/000343545","journal-title":"Curr Urol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(17)32100-0","article-title":"Flexible ureteroscopy in patients with nephrolithiasis associated with autosomal dominant polycystic kidney disease (ADPKD)","volume":"16","author":"Georgescu D","year":"2017","unstructured":"Georgescu D, Geavlete B, Multescu R, Ene C, Ene MA, Geavlete PA. Flexible ureteroscopy in patients with nephrolithiasis associated with autosomal dominant polycystic kidney disease (ADPKD). Eur Urol Suppl. 2017, 16:2963. 10.1016\/S1569-9056(17)32100-0","journal-title":"Eur Urol Suppl"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01882-z","article-title":"Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease","volume":"24","author":"Xu Y","year":"2020","unstructured":"Xu Y, Bai Z, Ma D, et al.. Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2020, 24:842-8. 10.1007\/s10157-020-01882-z","journal-title":"Clin Exp Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.02.2996","article-title":"V11-07 Ecirs (endoscopic combined intrarenal surgery) in the Galdakao-modified supine Valdivia position","volume":"197","author":"Scoffone CM","year":"2017","unstructured":"Scoffone CM, Ingrosso M, Cracco C. V11-07 Ecirs (endoscopic combined intrarenal surgery) in the Galdakao-modified supine Valdivia position. J Urol. 2017, 197:1284. 10.1016\/j.juro.2017.02.2996","journal-title":"J Urol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3483172","article-title":"Percutaneous nephrolithotomy under ultrasound guidance in patients with renal calculi and autosomal dominant polycystic kidney disease: a report of 11 cases","volume":"2017","author":"Wang X","year":"2017","unstructured":"Wang X, Yang X, Zhong X, Wang Z, Xue S, Yu W, Dong Z. Percutaneous nephrolithotomy under ultrasound guidance in patients with renal calculi and autosomal dominant polycystic kidney disease: a report of 11 cases. Adv Urol. 2017, 2017:3483172. 10.1155\/2017\/3483172","journal-title":"Adv Urol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/03915603221091082","article-title":"Supine PCNL in autosomal dominant polycystic kidney disease","volume":"90","author":"Choudhury S","year":"2023","unstructured":"Choudhury S, Kasim A, Pal DK. Supine PCNL in autosomal dominant polycystic kidney disease. Urologia. 2023, 90:123-9. 10.1177\/03915603221091082","journal-title":"Urologia"},{"key":"ref35","article-title":"Efficacy and safety of percutaneous nephrolithotripsy in autosomal dominant polycystic kidney disease","volume":"26","author":"Khorrami MH","year":"2012","unstructured":"Khorrami MH, Farahini F, Tadaion F, Alizade F, Zargham M, Izadpanahi MH, Mohammadi M. Efficacy and safety of percutaneous nephrolithotripsy in autosomal dominant polycystic kidney disease. J Endourol. 2012, 26:172.","journal-title":"J Endourol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80102-5","article-title":"Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease","volume":"6","author":"Bennett WM","year":"1985","unstructured":"Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1985, 6:400-4. 10.1016\/S0272-6386(85)80102-5","journal-title":"Am J Kidney Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.07.010","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary","volume":"107","author":"Torres VE","year":"2025","unstructured":"Torres VE, Ahn C, Barten TR, et al.. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 2025, 107:234-54. 10.1016\/j.kint.2024.07.010","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100021","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan GK","year":"2022","unstructured":"Rangan GK, Wong AT, Munt A, et al.. Prescribed water intake in autosomal dominant polycystic kidney disease. NEJM Evid. 2022, 1:2100021. 10.1056\/EVIDoa2100021","journal-title":"NEJM Evid"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418158-a-review-of-the-management-of-nephrolithiasis-in-autosomal-dominant-polycystic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:10Z","timestamp":1760539630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418158-a-review-of-the-management-of-nephrolithiasis-in-autosomal-dominant-polycystic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.94642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}